Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.

CONCLUSIONS: Serum miR-124 levels have utility as diagnostic biomarkers in patients with PDAC. These findings suggest, for the first time, that serum miR-124 levels may have prognostic impact in patients with PDAC. PMID: 27922430 [PubMed - in process]
Source: British Journal of Biomedical Science - Category: Laboratory Medicine Tags: Br J Biomed Sci Source Type: research